PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
32.82%
Revenue growth at 50-75% of IXX.DE's 62.64%. Martin Whitman would worry about competitiveness or product relevance.
48.93%
Gross profit growth at 50-75% of IXX.DE's 82.30%. Martin Whitman would question if cost structure or brand is lagging.
No Data
No Data available this quarter, please select a different quarter.
-144.66%
Negative operating income growth while IXX.DE is at 231.06%. Joel Greenblatt would press for urgent turnaround measures.
-375.30%
Negative net income growth while IXX.DE stands at 212.91%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-100.00%
Negative EPS growth while IXX.DE is at 218.18%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-100.00%
Negative diluted EPS growth while IXX.DE is at 218.18%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-100.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-100.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
42.51%
AR growth of 42.51% while IXX.DE is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
75.76%
We show growth while IXX.DE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
61.68%
Asset growth above 1.5x IXX.DE's 6.49%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-100.00%
We have a declining book value while IXX.DE shows 12.88%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
155.56%
Debt growth far above IXX.DE's 159.92%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
59.39%
We expand SG&A while IXX.DE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.